p16, Cyclin D1, and HIF-1<i>α</i> Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy

<table>Locoregional control and disease-free survival stratified by cyclin D1 status. </table>

International Journal of Otolaryngology

fig3

Figure 3

Figure 3: p16, Cyclin D1, and HIF-1<i>α</i> Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy 

Figure 3 | p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy 